Exicure (NASDAQ:XCUR) Releases Quarterly Earnings Results

Exicure (NASDAQ:XCUR) posted its quarterly earnings data on Tuesday. The company reported ($3.39) earnings per share (EPS) for the quarter, Zacks reports.

Exicure Stock Down 4.5 %

NASDAQ:XCUR traded down $0.59 during trading hours on Tuesday, hitting $12.40. 36,996 shares of the stock were exchanged, compared to its average volume of 567,374. The company’s 50 day moving average is $10.28 and its two-hundred day moving average is $9.31. Exicure has a twelve month low of $1.44 and a twelve month high of $36.00. The company has a market capitalization of $32.31 million, a P/E ratio of -5.99 and a beta of 3.84.

About Exicure

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.